Recent News

• 05.27.2025 - Rein Therapeutics Announces First Patient Dosed in RENEW Phase 2 Trial of LTI-03 in Patients with IPF
• 05.27.2025 - Rein Therapeutics Announces First Patient Dosed in RENEW Phase 2 Trial of LTI-03 in Patients with IPF
• 05.19.2025 - Rein Therapeutics Presents Two Posters at the American Thoracic Society 2025 International Conference
• 05.19.2025 - Rein Therapeutics Presents Two Posters at the American Thoracic Society 2025 International Conference
• 05.15.2025 - Rein Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
• 05.15.2025 - Rein Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
• 05.12.2025 - Rein Therapeutics Announces Initiation of RENEW Phase 2 Trial of LTI-03 in Patients with IPF
• 05.12.2025 - Rein Therapeutics Announces Initiation of RENEW Phase 2 Trial of LTI-03 in Patients with IPF
• 05.08.2025 - The Citizens Life Sciences Conference 2025
• 05.08.2025 - The Citizens Life Sciences Conference 2025

Recent Filings